2 studies found for:    10774589 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
Condition: HIV Infections
Interventions: Drug: Atevirdine mesylate;   Drug: Zidovudine;   Drug: Didanosine
2 Completed A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
Condition: HIV Infections
Interventions: Drug: Atevirdine mesylate;   Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine

Indicates status has not been verified in more than two years